Akso Health Group

NASDAQ:AHG

Financial - Credit Services

Financial Services
$1.36 +2.44%

+$0.03 today

Market cap
$1.16B
Beta
-1.02
P/E (TTM)
-3.1
EPS (TTM)
-$0.40
52W Low $1.07High $2.50

Volume 0.00M

Average 0.12M

AHG EBITDA

Earnings before interest, taxes, depreciation, and amortization; a proxy for operating profit before non-cash and financing charges.

Akso Health GroupNASDAQ: AHG

EBITDA · Q4 FY2025 · quarter ended Mar 2025

EBITDA turns negative

Q4 FY2025 EBITDA was -$624.7K, compared with $0 a year earlier. Trailing-twelve-month EBITDA was -$1.77M.

Context

  • EBITDA amounted to 12.0% of revenue in FY2025, down 345.8 pp from a year earlier.
  • EBITDA grew in size in 1 of the last 3 fiscal years.
  • FY2025 was the smallest annual figure in the 4 fiscal years shown.

What to watch

Whether next quarter's EBITDA reaches the consensus estimate of -$129.48M, a -49339.1% change from the same quarter last year.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2025
-$624.7K+0.0% QoQ
Last fiscal yearMar 2025
-$1.77M+79.5% YoY
LTMMar 2025
-$1.77M— YoY
EBITDA past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter—-49339.1%—
1 year+79.5%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA history

USD · from the income statement

Latest · FY2025
(1.77M) USD
Year-over-year change
+79.5%

EBITDA vs competitors

How AHG compares with its peers on the latest reported figures

  • Peers report in different currencies, so EBITDA is compared through growth and share of revenue rather than absolute size.
  • EBITDA amounts to 12.0% of revenue for AHG, versus a peer median of 17.3%.
AHG Competitors
EBITDA for AHG and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MOMOHello Group Inc.LTM Mar 2026CN¥1.77B CNY-5.2%-6.6%17.3%
AHGAkso Health GroupLTM Mar 2025-$1.77M USD——12.0%
JMIAJumia Technologies AGLTM Mar 2026-$43.97M USD+53.6%—21.6%
ZKHZKH Group LimitedLTM Mar 2026-CN¥60.75M CNY+70.8%—0.7%
Peer median (excluding AHG) —+53.6%-6.6%17.3%

Competitors are the stored peer set for AHG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Mar 2021
FY2022
Mar 2022
FY2023
Mar 2023
FY2024
Mar 2024
FY2025
Mar 2025
Revenue1.75M6M13.18M2.41M14.78M
Cost of Revenue544.57K5.39M11.91M2.29M15.06M
Gross Profit1.21M605.13K1.27M122.13K(281.53K)
Gross Margin69.0%10.1%9.6%5.1%-1.9%
Research & Development441.41K421.19K000
Selling, General & Admin2.09M3.06M15.54M8.76M3.64M
Operating Expenses28.36M3.87M15.54M8.76M166.02M
Depreciation & Amortization15.16K18.39K18.39K8.64M2.15M
EBITDA(28.9M)(3.19M)(14.27M)(8.64M)(1.77M)
EBITDA Margin-1646.8%-53.1%-108.2%-357.8%-12.0%
Operating Income(27.15M)(3.26M)(14.27M)(8.64M)(166.3M)
Operating Margin-1547.1%-54.3%-108.2%-357.8%-1125.4%
Interest Income00000
Interest Expense2.15M804.14K000
Other Income / Expenses23.34M(747.82K)1.2M(453.75K)34.07K
Income Before Tax(3.81M)(4.01M)(13.07M)(9.09M)(166.27M)
Pre-Tax Margin-217.1%-66.8%-99.1%-376.6%-1125.1%
Income Tax Expense482.98K92.82K17.55K24.99K(30.8M)
Net Income(34.83M)(16.85M)(1.36M)(9.46M)(134.98M)
Net Margin-1984.5%-280.8%-10.3%-391.8%-913.4%
EPS (Basic)(0.26)(2.55)(0.06)(0.45)(0.48)
EPS (Diluted)(0.27)(2.55)(0.06)(0.39)(0.48)
Weighted Avg Shares5.43M6.62M7.62M20.81M285.1M
Weighted Avg Shares (Diluted)5.43M6.62M7.62M23.83M285.1M

Akso Health Group

NASDAQ:AHG

Intrinsic Alpha fair value

Locked

Current Price

$1.36

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.